Patients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival

Press/Media: Press / Media

PeriodOct 20 2015 → Oct 23 2015

Media coverage

35

Media coverage

  • TitlePatients with intermediate-risk meningiomas who receive postoperative radiation therapy have excellent three-year progression-free survival
    Media name/outletNoodls
    CountryItaly
    Date10/23/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletReuters
    CountryUnited Kingdom
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletReuters
    CountryUnited Kingdom
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletIndividual.com
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletMarket Pulse Navigator
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletFat Pitch Financials
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletRCL Advisors
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletIndustrial Info Financials
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletUlitzer
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletBioSpace
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletWall Street Select
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletFinancial Content
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletRenewable Energy World
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletMarketplace
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletPettinga Financial Advisors
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletCrawford Financial Planning
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletMoneyShow.com
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletReliance Trust
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletSys-Con Media
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletCEOWorld Magazine
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletFranklin Credit Management Corporation
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletWall Street Business Network
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletSearchBug
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletTown Hall
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletVirtualization Conference & Expo
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletYahoo! Finance
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletFreshnews.com
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletTamar Securities
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletSys-Con Australia
    CountryAustralia
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletGood Day Sacramento
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletStock Nod
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletAsk.com
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients with intermediate-risk meningiomas who receive postoperative radiation therapy have excellent three-year progression-free survival
    Media name/outletCision Wire
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletU-T San Diego
    CountryUnited States
    Date10/20/15
    PersonsFrancisco G Cigarroa
  • TitlePatients With Intermediate-Risk Meningiomas Who Receive Postoperative Radiation Therapy Have Excellent Three-Year Progression-Free Survival
    Media name/outletMarketWired
    CountryCanada
    Date10/20/15
    PersonsFrancisco G Cigarroa